Get the app!
Back to Trades

RECURSION PHARMACEUTICALS, INC.

RXRXCIK: 0001601830

RECURSION PHARMACEUTICALS, INC. (RXRX) has recorded 45 insider filings from 7 unique insiders, totaling $13.7M in trading activity (net selling). Insiders have sold $11.6M while purchasing $0. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Gibson Christopher. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.

Total Volume
$13.7M
Purchases
$0
Sales
$11.6M
Unique Insiders
7

Recent Insider Trades (45)

Taylor Ben RChief Financial Officer
Filed Mar 18, 2026
Sell
$27.0K
1 sale
Khan NajatCEO and President, Director
Filed Feb 19, 2026
Other
$0
Taylor Ben RChief Financial Officer
Filed Feb 19, 2026
Sell
$41.4K
1 sale
Hallett DavidChief Scientific Officer
Filed Feb 19, 2026
Other
$0
Khan NajatCEO and President, Director
Filed Feb 10, 2026
Grant
$0
2 grants
Hallett DavidChief Scientific Officer
Filed Feb 10, 2026
Grant
$0
2 grants
Taylor Ben RChief Financial Officer
Filed Feb 10, 2026
Grant
$0
2 grants
Taylor Ben RChief Financial Officer
Filed Dec 30, 2025
Sell
$89.4K
1 sale
Khan NajatChief R&D Commercial Officer, Director
Filed Dec 29, 2025
Sell
$548.6K
1 sale
Gibson ChristopherChief Executive Officer, Director
Filed Dec 19, 2025
Sell
$180.0K
1 sale
Taylor Ben RChief Financial Officer
Filed Dec 17, 2025
Other
$0
Taylor Ben RChief Financial Officer
Filed Nov 26, 2025
Other
$0
Gibson ChristopherChief Executive Officer, Director
Filed Nov 19, 2025
Sell
$166.4K
1 sale
Taylor Ben RChief Financial Officer
Filed Nov 19, 2025
Other
$0
Khan NajatChief R&D Commercial Officer, Director
Filed Nov 19, 2025
Other
$0
Khan NajatChief R&D Commercial Officer, Director
Filed Nov 6, 2025
Grant
$0
1 grant
Gibson ChristopherChief Executive Officer, Director
Filed Nov 6, 2025
Sell
$208.4K
1 sale
Gibson ChristopherChief Executive Officer, Director
Filed Oct 24, 2025
Sell
$570.0K
1 sale
Gibson ChristopherChief Executive Officer, Director
Filed Oct 10, 2025
Sell
$604.0K
1 sale
Gibson ChristopherChief Executive Officer, Director
Filed Sep 26, 2025
Sell
$476.0K
1 sale
Taylor Ben RChief Financial Officer
Filed Sep 17, 2025
Other
$0
Gibson ChristopherChief Executive Officer, Director
Filed Sep 12, 2025
Sell
$471.0K
1 sale
Gibson ChristopherChief Executive Officer, Director
Filed Aug 28, 2025
Sell
$484.0K
1 sale
Taylor Ben RChief Financial Officer
Filed Aug 19, 2025
Other
$0
Khan NajatChief R&D Commercial Officer, Director
Filed Aug 19, 2025
Sell
$202.2K
1 sale
Gibson ChristopherChief Executive Officer, Director
Filed Aug 19, 2025
Other
$0
Gibson ChristopherChief Executive Officer, Director
Filed Aug 13, 2025
Sell
$3.3M
3 sales